Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...

Fintel reports that on March 13, 2025, Citigroup initiated coverage of Moderna (NasdaqGS:MRNA) with a Neutral recommendation.

There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.

In the Boston area, three months into the new year, the mood in the biotech industry has soured and the outlook has clouded.

Klinger joined the Cambridge, Massachusetts-based pharmaceutical company in 2021, when Moderna's stock was trading at around ...

mRESVIA ®is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 /Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products ...

A two-story lab building in East Cambridge is proposed for redevelopment at six stories in a process called “contract zoning” ...

An ambitious start-up embodies new optimism that artificial intelligence can turbocharge scientific discovery.

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

and Cambridge. Moderna will rub shoulders there with the likes of the UK Health Security Agency (UKHSA), with which it is working on early vaccine development for future pandemic threats ...

Artificial intelligence-powered scientific discovery startup Lila Sciences is the latest company to emerge from Flagship ...